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Summary.-Using cultured cells derived from human malignant effusions, hetero-
antisera were raised in rabbits. The antisera were sequentially absorbed on various
human non-tumour cells, reactivity being monitored by immunofluorescence and
125I-labelled staphylococcal protein A assays. The absorbed antisera possessed
common reactivity to all tumour cells assayed. This reactivity was not histogenically
determined, and our data suggest that it was not directed to oncofoetal antigens.
A CRUCIAL step in the application of
immunology to the management of cancer
is the demonstration of tumour-associated
antigens on human neoplasms. A wide
variety of approaches to this problem
has been made (Grimm et al., 1976;
Gorsky, Vanky and Sulitzeanu, 1976;
Richman, 1976; Hellstrom and Hellstrom,
1974a; Shiku et al., 1976) including the
production ofheteroantisera to membrane
antigens of cancer cells (Mohanakumar,
Metzgar and Miller, 1974). This latter
approach is of special interest, because
it allows the production oflarge quantities
of serum which can be used to analyse
tumour cell surfaces. In addition, im-
munization of another species is likely
to result in the production offree antibody
which can be detected in antibody-
binding techniques; whereas the demon-
stration of antibody to tumour antigens
in sera of cancer patients may be rendered
difficult because antibody may be com-
plexed with antigen, especially in patients
with large tumour masses (Hellstrom and
Hellstrom, 1974b).
Antibodies to membrane antigens un-
modified by preparative procedures are
more likely to be obtained by injection
ofwhole tumour cells than ofcell fractions.
However, sera produced by either method
are likely to contain antibodies to "nor-
mal" human antigens, and attempts have
been made to improve the specificity of
these sera for tumour antigens by coating
the immunizing cells with antibodies
raised to "normal" antigens, thereby
reducing the immunogenicity of the latter
(Greaves et al., 1975). Nonetheless, a
number of problems concerning the pro-
duction of heteroantisera to tumour anti-
gens remain, namely:
(i) Whilst adequate numbers of leuk-
aemia cells can be obtained to immunize
species such as the rabbit (Brown, Capel-
laro and Greaves, 1975; Stuhlmiller and
Seigler, 1975) it is more difficult to obtain
adequate numbers of cells from solid
tumours. Even when attempts are made
to culture cells from solid tumours in
order to obtain sufficient quantities for
immunization, it has still proved difficult
to obtain adequate numbers of cells
free from contaminating "normal" cells.
(ii) Despite attempts to improve speci-
ficity of sera as outlined above, antibodies
to "normal" antigens may still be present.
In order to screen for such antibodies,
it is necessary to have a variety of
"normal" target cells. Furthermore, if
antibody binding to these target cells
is demonstrated, methods of absorption
are required which involve the production
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for this purpose, and the development
of techniques of absorption which avoid
loss of antisera.
(iii) Methods of assay for antibodies to
tumour-associated antigens should be de-
signed to demarcate clearly between anti-
bodies binding to surface antigens and
antibodies binding to cytoplasmic anti-
gens.
In addition, because ofpossible tumour-
cell heterogeneity, it is valuable to have
techniques which measure not only overall
binding of antibody to target cells, but
also demonstrate binding to individual
cells within the tumour population.
In this paper we describe studies which
attempt to overcome some of these
problems. We have used malignant cells
grown from effusions as both immunizing
populations and as target cells for anti-
body binding assays. We have found
that we can obtain adequate numbers of
cells for both purposes with relatively
few passages in vitro. Furthermore, we
have cryopreserved target cells to allow
studies over a period of time. In parallel,
we have obtained cultures of a variety
of types of normal human cells for use
as specificity controls. We have also
used cell monolayers for absorption.
Finally, we have employed an indirect
immunofluorescence technique, using vi-
able target cells, to demonstrate antibody
binding to surfaces of individual tumour
cells. In addition, we have performed
radioisotope-binding assays, utilizing sta-
phylococcal protein A conjugated to 1251
in order to measure overall binding of
IgG antibody to tumour cells. Our results
suggest that these methods may provide
valid approaches for the demonstration
of antibodies to tumour-associated anti-
gens.
MATERIALS AND METHODS
Cell culture
All cells were grown in glass medicine
bottles (usually the 11 size) as monolayer
cultures in 30 ml of tissue culture medium
(RF20) which consists of 20 ml of foetal
calf serum (Flow Labs) 80 ml of RPMI 1640
49
(Gibco Biocult), 1 ml of penicillin/strepto-
mycin at 10,000 u/ml (Gibco Biocult) and
1.5 ml of 200 mm glutamine (Gibco Biocult)
giving a final volume of 102-5 ml of stock
solution. The flasks were gassed in 95%
air-5% C02 and incubated at 370C. When
cultures were reaching confluency, cells were
removed from flasks in a mixture of 0 25%
trypsin (Gibco Biocult) in Ca and Mg free
Earle's balanced salt solution (BSS) and
Versene (1/5000 strength, Gibco Biocult) in
a ratio of 1: 4 to give the working solution.
(a) Malignant cells.-Malignant ascitic and
pleural effusions were obtained fresh and
sterile from local hospitals. The effusions
were either added to 11 flasks with no
further manipulation, or centrifuged at
1500 rev/min for 45 min; the supernatant
was then removed, and the pellet was
resuspended in tissue culture medium and
pipetted into a flask (Souhami, Owen and
Seeger, 1974). Either method normally
yielded a confluent monolayer in about
one week, the centrifugation technique
accelerated this process, so that confluence
was reached 2-3 days earlier. The cells
were passaged until sufficient numbers were
obtained for the immunization programme
and a stock of cells was cryopreserved using
a controlled biological freezer (Cryosan
BV4) under optimal conditions (manuscript
in preparation) and stored in a liquid-N2
refrigerator.
(b) Non-malignant cells.-All normal cells,
except a continuous line of Chang cells
(human liver) were obtained from solid
tissue which, after transportation to the
laboratory, was chopped into 1 mm3 frag-
ments or less and set up in tissue culture.
They grew to form monolayers which could
then be treated as above.
Production of sera
(a) Anti-human-lymphocyte serum (ALS).-
Tonsils, obtained from the local hospital,
were washed in BSS supplemented with
antibiotics to reduce the risk of inducing
septicaemia in the rabbit to be immunized.
Tonsils were teased in BSS and the suspension
was allowed to stand for 10 min to allow
large particles to settle. The supernatant
was removed and centrifuged at 225 g for
10 min. The pellet containing 1-_409 lympho-
cytes was resuspended in 1 ml of BSS and
injected into the marginal ear vein of a
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rabbit. The rabbit was bled 14 days later;
the serum had a titre of greater than 1 : 1000
to Chang cells by immunofluorescence.
(b) Heteroantisera to tumour cells.-Cell
suspensions were obtained from 16 confluent
11 flasks (10-14 x 106 cells in total). The
pooled cells were gassed and incubated for
4 h at 370C to allow cell-surface antigens
to regenerate. After centrifugation at 225 g
for 10 min, the supernatant wias removed,
and twice the packed-cell volume of ALS
was added. The cells were resuspended and
constantly agitated at room temperature
for 1 h. After centrifugation, the supernatant
was removed and the cells washed once in
BSS before they were injected in 1 ml of
BSS into the marginal ear vein of a rabbit.
The procedure was repeated after a 2 week
interval (in the case of melanoma cells,
3 immunizations were performed). Fourteen
days after the final immunization, rabbits
were exsanguinated under barbiturate anaes-
thesia. Sera were heat-inactivated for 1 h
at 56°C and stored in aliquots at -20°C.
In total, 4 antisera were raised to the follow-
ing cells: colonic carcinoma, breast car-
cinoma (1), ovarian carcinoma (1) and malig-
nant melanoma.
Antibody binding assays
(a) Indirect immunofiuorescence (IF) as-
say.-Target cells were seeded into 5 cm
glass Petri dishes containing 10 mm diameter
coverslips; 3-10 x 104 cells in a total volume
of 5 ml of RF20 were added to each dish.
The dishes were incubated in a 5%0 C02-in-air
atmosphere overnight at 37°C. The cover-
slips, covered by a subconfluent layer of
cells, were removed and gently washed in
a beaker of RPMI 1640 buffered with Hepes
at 370C. Excess medium was drained from
the coverslips by touching their edges to
filter paper and each coverslip was placed
on a small stub in a large Petri dish and
covered by a lid to prevent evaporation.
It is important to note that cells must be
kept moist and adequately buffered during
the test.
Test antisera were made to wAorking
dilutions in RPMI 1640 (Hepes) and 20 1tl
was added to each coverslip. After 30 min
incubation at room temperature, each cover-
slip was gently washed in BSS, drained and
replaced on its stub. Polyvalent fluorescein-
conjugated sheep anti-rabbit serum (Wrell-
come Reagents Ltd, England) was made
up to a working dilution of 1 :16 with
RPMI 1640 (Hepes) and 20 -N was added
to each coverslip. Coverslips wNere incubated
for 30 min at room temperature and washed
gently x 5 with BSS. Each coverslip was
then fixed -%Nith 30 ttl of methanol for 10 min,
drained and inverted (cell-side down) on
to a microscope slide using 30o% glycerol
as mountant. The edges of the coverslip
wNere sealed to the slide with nail varnish.
Slides wNere scanned in a Leitz epi-illumination
microscope (Ploenopak 2) using an oil-
immersion x 60 objective.
Controls were set up in parallel, using the
same procedure except that sera obtained
from rabbits prior to immunization wiere
added instead of immune sera. In addition,
tests were performed on cells using media
alone in place of serum prior to the addition
of conjugate.
(b) 125I-staphylococcal protein A (1251-SpA)
assay. The basic principle is the saine as
that utilized in the indirect immunofluo-
rescence assay; in this case 1251-SpA replaces
the fluorescein conjugate. Ten 1u of cell
suspension was added to each w%ell of a
micro-wrell plate (Falcon Plastics Code No.
3034) and culture mediumNwas added to
the interspaces betwreen wells to humidify
the plate. The plate w%as then placed in a
humidified desiccator, gassed with air/500
C02 and incubated at 37°C overnight.
The number of cells required to form a
confluent monolayer varies between cell
types (e.g. 15 x 103 Chang cells per well,
2 X 1(3 adult fibroblasts per well). This
was determined empirically. Prior to the
start of the assay, the plates were immersed
in phosphate buffered saline (PBS) and
gently rocked to remove any unattached
cells. The wells w-ere then firmly blotted
twice with filter paper to remove most of
the fluid. Ten microlitres of diluted sera
(immune or control) or tissue culture media
was pipetted into appropriate wells. Plates
were incubated for 30 min at room tempera-
ture and washed 2 x in 150 ml lots of PBS
and blotted.
SpA (Pharmacia) was iodonated by the
Chloramine-T method (Hunter, 1973) 150 mg
of SpA was reacted with 1 mC. of Na1251I
(Radiochemicals, Amersham, England) and
the sp. act. wAas usually about 6 mCi/mg
SpA. A 1: 250 dilution of 1251--SpA in culture
mediuin (Hepes) was added to each well
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in 10 jkl aliquots and incubated as above.
Plates were washed 4 x in PBS (300 ml in
total) blotted, air dried and sprayed with
Nubecutane (Astra Chemicals Ltd) to prevent
cell detachment. Wells were cut out on a
band saw and counted on a gamma counter.
At each stage in the assay, the condition
of the cells was checked using an inverted
microscope.
Each set of data was obtained from wells
in triplicate or quintuplicate.
Absorption of sera
Antisera were absorbed on confluent
monolayers of cells grown in large glass
flasks (surface area, 180 cm2). Culture medium
was drained to the base of the flask by
incubating the flask vertically "on end" for
20 min. This medium was removed and the
flask was tightly stoppered and replaced
"on end" for a further 20 min, so that any
residual medium could be removed. The
antiserum to be absorbed was then pipetted
into the flask and allowed to cover the
cell monolayer. The cells and antiserum
were incubated together for 45 min at
37°C after which the flask was again placed
"on end" and allowed to stand for 10 min.
The antiserum was then recovered.
Three batches of anti-melanoma serum
all derived from the same serum pool,
were absorbed separately on cell monolayers.
All 3 batches were diluted 1:5 with foetal
calf serum prior to absorption. Subsequently,
batch 1 was absorbed X27 on Chang cells,
X 7 on foetal fibroblasts, X2 on fibro-
adenoma cells and finally x 3 on colon
carcinoma cells. Batch 2 was absorbed X35
on Chang cells, x 3 on foetal fibroblasts,
x2 on pleural cells and finally x 2 on
ovarian carcinoma. Batch 3 was absorbed
x35 on Chang cells, x 4 on pleural cells and
finally x5 on colon carcinoma.
Three batches of anti-breast-carcinoma
serum, all derived from the same serum
pool, were also absorbed separately on cell
monolayers. Batch 1, but not batches 2
and 3, were diluted 1:5 with foetal calf
serum prior to absorption. Subsequently, batch 1 was absorbed x 20 on Chang cells
and x 3 on foetal fibroblasts. Batch 2 was
absorbed x 34 on Chang cells and x 3 on
foetal fibroblasts. Batch 3 was absorbed
X 30 with Chang cells, X6 with foetal
fibroblasts, x3 with pleural cells (1), x 6
with pleural cells (2) and finally X 3 with
ovarian carcinoma.
Absorption of anti-ovarian carcinoma and
anti-colon-carcinoma sera with Chang cells
removed most antibody-binding activity to
all cells, so these sera were not absorbed
further.
RESULTS
Target cell characteristics
Cytocentrifuge preparations made from
fresh malignant effusion fluid showed
the presence of normal blood cells and
large cells with prominent nucleoli, vari-
able nuclear: cytoplasmic ratios and some-
times multinucleate. Incubation of effu-
sion fluid with polystyrene particles shows
that these large cells are not phagocytic,
whereas a number of smaller cells (pre-
sumably macrophages and polymorphs)
take up particles under the same condi-
tions (Fig. 1).
Confluent monolayers were usually
found after 4-5 days' incubation of
effusion fluid, although a proportion of
effusions failed to give cell growth.
Some of the effusions which yielded
confluent cultures are listed in Table I.
A variety of cultures of cells of non-
malignant origin are also listed in this
table. These cells form a series of normal
controls.
Cells from malignant effusions grow in
a disorganized way and do not show
growth patterns characteristic of either
fibroblasts or normal epithelial cells (Fig.
2). Cell size is heterogeneous and cells
have numerous cytoplasmic processes and
granular refractile cytoplasm. Granularity
is a feature of all effusion cells, and
electron-microscope studies suggest that
it may be due to lipid inclusions. The
cells grown from malignant-melanoma
effusion fluid failed to show melanosomes
in the electron microscope and were
DOPA-oxidase-negative, but biopsies ex-
amined in the Pathology Department
showed that, whereas the primary lesion
producedmelanin, secondaryliverdeposits
did not.
The cells obtained by passaging primary
cultures did not phagocytose polystyrene
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Fie. 1.-Cytocentrifuge preparation of effusion fluid of a patient with malignant melanoma. Tho
cells obtained from the effusion fluid were incubated with polystyrene particles to identify phago-
cytic cells. The cell suspension was cytocentrifuged, air dried and stained with Giemsa. A phagocytic
cell with intracytoplasmic polystyrene particles can be seen on the middle left. A number of large,
non-phagocytic cells can be seen.
Designation
Melanoma
Breast carcinoma (1)
Breast carcinoma (2)
Breast carcinoma (3)
Breast carcinoma (4)
Colon carcinoma
Ovarian carcinoma (1)
Ovarian carcinoma (2)
Cervical carcinoma
Fibroadenoma
Pleural cells (1)
Pleural cells (2)
Adult fibroblasts
Foetal fibroblasts
Chang cells
Source
Ascites
Pleural effusion
Pleural effusion
Ascites
Ascites
Ascites
Ascites
Ascites
Ascites
Breast biopsy
Parietal pleura
Parietal pleura
Epimysium
Foetal thymus*
Normal liver (Murphy
and Landau, 1962)
* Obtained from a foetus of 8 weeks' gestation.
particles suggesting no contamination by
macrophages or granulocytes. The growth
rate of tumour-cell cultures usually de-
clines after about 15 in vitro passages.
Early passages were used preferentially
in assays. Cryopreservation of tumour
cells has enabled us to use early-passage
material over a period of time.
Cells from normal tissues grew well
after an initial lag period. Those derived
from connective tissue exhibit a typical
fibroblast morphology with parallel arrays
of cells. The cultures of foetal fibroblasts
grew particularly well and maintained
their growth potential over 30 in vitro
passages.
Maintenance of target cells
The tumour cells used were all cryo-
preserved, they all grew well after cryo-
preservation with the exception of breast
carcinoma (1), for this reason there is a
paucity of data with respect to the
1251-SpA assay, as insufficient cell numbers
were obtained for use in this assay.
However, sufficient numbers of cells were
obtained for both assays with all other
cell types.
Reactivity of anti-tumour sera with Chang
cells
Antisera raised against all tumour-cell
types reacted strongly with Chang cells
in both antibody binding assays (Tables
TABLE I.-Cell Types and Origins
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FIG. 2. Melanoma cells in monolayer culture. Melanoma cells were plated on to coverslips at an
early passage and stained with toluidine blue. The irregular growth pattern, with overlapping
of cells, heterogeneity of cell size, cytoplasmic processes and prominent nuclei can clearly be
seen.
II, III and IV). Titres of antibody up
to 1: 2000 were found, indicating that
the sera require extensive absorption
with Chang cells to remove antibodies to
''normal" human antigens.
Reactivity of Chang-cell-absorbed sera with
other cells
Twenty or more absorptions using
confluent monolayers of Chang cells in
large flasks were required to remove
anti-Chang activity. However, after all
activity to Chang cells had been removed,
residual antibody-binding activity in anti-
melanoma and anti-breast-carcinoma sera
to tumour cells was detected in both
assays (Tables II, III, IV and Fig. 4).
This could not be removed by further
absorption with Chang cells. In the case
ofanti-ovarian-carcinoma serum and anti-
colon-carcinoma serum, very little residual
activity could be demonstrated, and these
two sera were not examined further.
It should be noted that the immuno-
fluorescence pattern indicates binding of
antibody to membrane antigens (Fig. 3).
This is expected, since tests were carried
out on unfixed cells.
Activity of Chang-absorbed sera for
human cells other than tumour cells was
noted in both assays (Tables II, III and
IV). Steps were taken to remove this
activity by absorbing both anti-melanoma
and anti-breast-carcinoma sera with foetal
fibroblasts. One batch of anti-melanoma
serum (batch 3) was absorbed, however,
with pleural cells instead of foetal fibro-
blasts (Table III).
Reactivity of anti-tumour sera absorbed by
both Chang cells and foetal fibroblasts
Further absorption of serum with foetal
fibroblasts removed activity to these
cells, but left good residual activity to
tumour cells in the case of anti-melanoma
serum and anti-breast-carcinoma serum
(Tables II and IV). In addition to the
loss of activity to foetal fibroblasts,
activity to certain primary cultures of
normal human cells was also removed by
absorption on fibroblasts monolayers. For
instance, activity to pleural cells (1) and
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TABLE II.-Rabbit Anti-human-melanoma Serum, Batches 1 and 2
Absorbed with
Unabsorbed
Chang cells
Foetal fibroblasts
Batch 1
Fibroadenoma
Batch 2
Pleural cells (2)
Batch 1
Colon carcinoma
Batch 2
Ovarian carcinoma
Target cells
Melanoma
Chang
Chang
Melanoma
Foetal fibroblast
Foetal fibroblasts
Melanoma
Breast carcinoma (2)
Breast carcinoma (3)
Cervical carcinoma
Colon carcinoma
Ovarian carcinoma (1)
Adult fibroblasts
Fibroadenoma
Pleural cells (1)
Pleural cells (2)
Fibroadenoma
Pleural cells (2)
Melanoma
Colon carcinoma
Ovarian carcinoma (1)
Colon carcinoma
Ovarian carcinoma (1)
Melanoma
Cervical carcinoma
Antibody titre by
IF*
Batch 1 Batch 2
1: 8192
1: 2048
-ve -ve
1 : 32
1:8 1:8
-ve
1 :16
1:4
1:8
1:8
-ve
-ve 1 :4
-ve -ve
1 :4 1 :4
-ve
-ve -ve
1:16 1:8
1:4
-ve
-ve
-ve -ve
Antibody titre by
1251-SpA assayt
Batch 1 Batch 2
1 :8192
1 :1056
-ve
1:8
1:8
-ve
1:8
1 :4
1:32
1:2
1:2
1 :2
1 :4
1 :8
-ve
-ve
-ve
1 :4
-ve
-ve
1 :8
1:8
1 :4
-ve -ve
-ve
-ve -ve
-ve -ve
* In the IF test, the titre of an antibody is defined as the lowest antiserum dilution giving distinct mem-
brane immunofluorescence; the latter was never observed using rabbit serum obtained prior to immunization
or medium alone.
t In the 1251-SpA assay, the titre of an antibody is defined as the lowest dilution of antisera whose arith-
metic mean -s.e. gave a higher value than the arithmetic mean of the control wells +s.e. Control wells
were incubated with rabbit serum drawn prior to immunization or medium alone. The latter two gave
comparable results except in the case ofserum drawn from the rabbit prior to immunization with melanoma
cells. Here, a low titre of antibody was detected and this could be absorbed entirely with Chang cells.
fibro-adenoma cells was lost in the case
of anti-melanoma sera (batch 1) and
anti-human breast-carcinoma serum. How-
ever, with certain other normal human
cells, low levels of antibody activity
were still detected, i.e. pleural cells
(2) were still reactive with both anti-
melanoma and anti-breast-carcinoma sera
(Tables II and IV). In both cases, it
should be noted that IF tests indicated
that only certain cells in the total cell
population were positive.
Because absorption with foetal fibro-
blasts may remove activity to oncofoetal
antigens, Batch 3 of the anti-melanoma
sera was absorbed with pleural cells
after preliminary Chang absorption. How-
ever, the results (Table III), indicated
that little more reactivity to tumour
cells was left by this procedure than
following absorption by foetal fibroblasts.
Reactivity of sera absorbed with Chang
cells, foetal fibroblasts and either pleural
cells and/or fibroadenoma cells
This further absorption removed acti-
vity to all normal human cells, but
activity remained to tumour cells with
the following antisera: anti-melanoma
serum (Batches 1 and 2), anti-breast-
carcinoma serum (Batch 3). Batches 1
and 2 of anti-breast-carcinoma sera were
not further studied because they had
low titres to the breast carcinoma (1)
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TABLE III.-Rabbit Anti-human-melanoma Serum, Batch 3 (seefootnote to Table II)
Absorbed with
Unabsorbed
Chang cells
Pleural cells (1)
Colon carcinoma
Target cells
Melanoma
Chang
Chang
Melanoma
Fibroadenoma
Pleural cells (1)
Melanoma
Cervical carcinoma
Colon carcinoma
Ovarian carcinoma (1)
Fibroadenoma
Foetal fibroblasts
Pleural cells (1)
Pleural cells (2)
Colon carcinoma
Melanoma
Fibroadenoma
Foetal fibroblasts
Breast carcinoma (1)
Cervical carcinoma
Antibody titre by
IF
1 : 8192
1 : 2048
-ve
1 :64
1: 16
1: 16
1 :4
1:8
1:4
1:2
-ve
1 :4
-ve
-ve
-ve
-ve
Antibody titre by
125I-SpA assay
1 :8192
1 1056
-ve
1 :16
1 : 16
1 :16
1 :4
1: 16
1:2
-ve
-ve
-ve
-ve
-ve
-ve
-ve
TABLE IV.-Rabbit Anti-human-breast-carcinoma (1) Serum,
(seefootnote to Table II)
Batches 1, 2 and 3
Absorbed by
Unabsorbed
Chang cells
Foetal fibroblasts
Pleural cells (2)
and
Pleural cells (1)
Ovarian carcinoma
Target cells
Breast carcinoma (1)
Chang
Chang
Breast carcinoma (1)
Foetal fibroblasts
Fibroadenoma
Foetal fibroblasts
Breast carcinoma (1)
Breast carcinoma (3)
Breast carcinoma (4)
Cervical carcinoma
Colon carcinoma
Melanoma
Ovarian carcinoma (1)
Ovarian carcinoma (2)
Fibroadenoma
Pleural cells (1)
Pleural cells (2)
Pleural cells (1)
Breast carcinoma (1)
Melanoma
Ovarian carcinoma (1)
Fibroadenoma
Ovarian carcinoma (1)
Breast carcinoma (1)
Cervical carcinoma
Melanoma
Antibody titre by IF
Batch 1 Batch 2 Batch 3
1 : 2048
1 :1024
-ve -ve
1:16 1:64
1:8 1:4
1:4
-ve -ve
1:8 1:16
1 :4
1:4
1:4
1 :8 1:8
1 :16 1:4
1:8
1:4
-ve
-ve 1:2
1 :2 1 :2
-ve
1 : 8
-ve
1:16
1: 32
1:4
1:8
Antibody titre by 1251-SpA
Batch 1 Batch 2 Batch 3
1 : 1024
1: 16
1:8
-ve
1:4
1:4
-ve
-ve
-ve
1:8
1 :4
1:8
1:8
1 :8
-ve
-ve
-ve
-ve
-ve
-ve
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FIG. 3.-Indirect immunofluorescence. The photograph on the left is phase contrast; the one on
the right is of the same cell in UV light. Membrane fluorescence can be seen. Targets are melanoma
cells.
cells. In each instance, the binding of
the antisera was not specific for the
immunizing tumour-cell type, but binding
to similar titres with other tumour cells
was found (Tables II, III and IV). Al-
though titres were low, membrane im-
munofluorescence was bright and the
entire cell population was stained. The
counts obtained in the 1251-SpA assay
were quite high (see Fig. 4).
Absorption of residual activity for tumour
cells by unrelated tumour cells
The fact that various tumour cells
reacted with the same sera suggested
that common antigens may be being
detected, and this was confirmed by
showing that absorption ofanti-melanoma
serum with colon carcinoma or ovarian
carcinoma cells removed all activity to
both tumours as well as to other tumour-
cell types (Tables II, III and IV). Simi-
larly, absorption of anti-breast-carcinoma
sera with ovarian carcinoma cells gave
us comparable results. In the case of
anti-melanoma serum (Batch 3) where
some reactivity to normal cells was still
present prior to absorption with unrelated
tumour cells, all reactivity to normal and
tumour cells was removed.
DISCUSSION
In this study we have employed
primary cell cultures so as to avoid
problems that are associated with use
of established cell lines, such as con-
tamination with Hela cells (Grimwade,
1976) viral contamination and loss of
antigenicity through prolonged culture
(Levey, 1973). Our primary cell cultures
have limited proliferative potential and
so, in order to allow experiments over a
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Fic(. 4.--251-staphylococcal protein A assay.
Mtelanioma cells were tised as targets, aniti-
melanoma serum at various stages of
absoIption are shown. The uipper curve
is the u-nabsorbe(d seIum (liltite(l 5 initi-
ally to make it (lirectly compaIable with
the absorbed sera. The middle curve is
the antiserum after 35 absorptions on
Chang monolayers. The lower cuIrve is
anti-melanoma sertum absorbed1 with Chang
x 27, foetal fibroblasts x 7, fibroadlenoma
cells x 2 andl colon carcinoma x 3. The
control was the inormal pre-immuinizedl
rabbit seruim at a (dilution of 1: 10, which
is dlirectly comparable with the lowest
(lillition of the antisera. Each point on the
cturve is showni ±s.e. of its arithmetical
mean from triplicate samples.
period of time, we have cryopreserved
cells, preferably after only one or two
passages. This technique has permitted
the study of a given primary culture over
many months. In these studies, the
primary neoplastic cell cultures used for
raising antisera were selected for two
reasons. Firstly, because of their initial
high proliferative capacity, large numbers
of cells could be obtained. In some
cultures, initial low growth rates were
observed and in some cases this could
be related to the p)atient's previous
chemotherapy. Secondly, a range of cul-
tures from differenit primaries was selected,
namely colon carcinoma, breast carcinoma,
ovarian carcinoma and malignant melan-
oma, in order that tumour-associated
antigens which might be histogenically
determined could be studied. A variety
of normal cells were chosen as controls for
the following reasons:
(i) Foetal fibroblasts were used in ani
attempt to exclude the presence of
common embryonic and tumour antigens.
It has been shown that tumour cells have
antigens on their cell surfaces which
are common to embryonic tissues but
are not found on adult cells. Further-
more, these embryonic antigens are able
to induce cytotoxic "T" cells and the
production of antibody which can block
the cytotoxic action of t,he "T" cells
(Hellstrom and Hellstrom, 1975). Cross
reactivity between tumours of the same
histological type may be due to the
expression ofembryonic antigens (Baldwin
and Embleton, 1974).
(ii) Benign fibroadenoma cells were in-
cluded as there is evidence that there is
antigenic cross reactivity between benign
and malignant breast tumours as assessed
by the microcytotoxicity assay (Avis,
Mosonov and Haughton, 1974).
(iii) Normal fibroblasts were cultured
from epimysium obtained from a patient
with no evidence of malignancy as a con-
trol for "normal" adult human antigens.
(iv) Parietal pleural cells were obtained
at post mortem from recently deceased
men with no evidence of malignant
disease. Pleural cells are an important
control because it has been claimed that
cultures from malignant effusions contain
large numbers of mesothelial cells, some-
times to the total exclusion of tumour
cells (Cailleau et al., 1974; Whitehead and
Hughes, 1975). Unfortunately there is,
as yet, no generally applicable technique
to ascertain whether a given human cell
culture is tumorous or not, and our
attempts to grow these "'tumour" cells
in nude mice have been unsuccessful.
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Thuis, any conclusions about the nature
of cells obtained from malignant effusions
is still speculative.
In order to minimize the immuno-
genicity of "normal" human antigens
in the rabbit, target cells were coated
with anti-lymphocyte serum (ALS) as
originally described by Weiner, Hubbard
and Mardiney in 1972. Our results show
that the technique does not avoid anti-
bodies to such antigens, since we found
high antibody titres against normal cells.
Success has been claimed in defining a
leukaemia-specific antigen by injecting
ALS coated acute lymphoblastic leu-
kaemia cells into rabbits (Brown et al.,
1975) but whether this success is due to
antibody coating is not known.
We have, therefore, had to use absorp-
tion techniques to remove unwanted
antibodies. The use of cell monolayers as
an immunoabsorbent has several ad-
vantages over the more conventional
methods using cell pellets. Thus, antisera
are exposed only to the surfaces of viable
cells and several other potential problems
are avoided. The use of fixed cells may
lead to alterations of antigenic deter-
minants. If cell suspensions of naturally
adherent cells are used, they may not
express some antigens that are expressed
in the adherent state, and if cell homo-
genates are used they will contain cyto-
plasmic products some of which are
proteolytic. Finally, in this method, cells
are not subjected to trypsinization, and
so lengthy incubation periods to allow
the regeneration of surface antigens are
avoided. The necessity to absorb with
foetal calf serum is also obviated, because
the monolayers used for absorption are
grown in culture medium containing
serum some of which will be incorporated
into cell membranes (Jrie, Irie and Morton,
1976). Sera can undergo multiple absorp-
tions with minimal dilution by this
method, which, coupled with the other
disadvantages of pelleting techniques, led
us to abandon the latter after a pre-
liminary trial.
Both IF and SpA assays have been
used in this work to complement each
other. IF, though sensitive and allowing
the detection of small nuimbers of positive
cells in a population, which is an ad-
vantage, particularly if the homogeneity
of the population is in question, does
however have the disadvantages of sub-
jectivity in interpretation and difficulty
in quantitation. The 1251-SpA assay is
objective and semiquantitative and allows
detection of IgG subclasses 1, 2 and 4
(Kronvall and Williams, 1969). The lack
of detection of other classes has not been
a problem, as judged by the concordaance
of results obtained in the two assay
systems, presumably because the majority
of antibodies binding to the target cells
are IgG.
Chang cells, which are derived from
normal liver, are a convenient primary
immunoabsorbent, because they are ad-
herent and proliferate rapidly. Thus
large numbers can be obtained readily.
However, their use could be criticized,
because they are an established cell line
and so one may expect "tumour-asso-
ciated" antigens related to continuous
proliferative potential. While we cannot
exclude this possibility, they are histo-
genically distinct from our tumour cells
used for immunization and so it is unlikely
that antibodies to tissue-related tumour
antigens would be removed.
Our experiments show that most of
the antibody response elicited by tumour
cells in rabbits is directed against antigens
present on non-tumour cells. Following
absorption with Chang cells, the reactivity
to the immunizing tumour decreased
by about 50-fold. Subsequent absorptions
with Chang cells did not further reduce
this reactivity, indicating that the re-
maining activity was against antigens
not present on Chang cells. Much of this
reactivity was directed against other
non-malignant cells such as pleural cells,
fibroblasts, benign-breast-tumour cells (all
from adult tissues) and foetal fibroblasts.
This reactivity was removed by sequential
absorptions with these cells. However,
residual reactivity remained towards the
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immunizing tumour cells and to other
unrelated tumours. Though the titres
were low, definite staining was present
with IF, and significant counts were
recorded in the 1251-SpA assay (up to
14 x control values). The remaining re-
activity to the tumour cells was com-
pletely removed by absorption with a
tumour other than the immunizing tu-
mour. These results indicate that all
tumour cells grown from effusions have a
common antigenicity, irrespective of their
tissue of origin.
To ensure that the absorption with
foetal fibroblasts had not removed anti-
bodies to foetal antigens which may be
responsible for the histogenic pattern
of human tumour antigens described by
other workers, anti-melanoma serum
(Batch 3) was absorbed with Chang and
pleural cells (1) (see Table III). The
serum remained reactive to the tumours
and some normal cells at this stage. The
serum was then absorbed with colon
carcinoma, and this removed all reactivity
to tumour and non-tumour cells tested.
The experiment indicates firstly, that
absorption with foetal fibroblasts is not
responsible for the failure to detect
histogenically-determined antigens in the
)revious experiments, and secondly, the
great similarity between the set ofantigens
on the colon carcinoma cells and the set
on the melanoma cells.
Other workers have claimed that tu-
mour cells share common tumour antigens
(Dickinson, Smith and Dyson, 1976;
Seibert et al., 1977; Grimm et al., 1976)
and our results are more in keeping with
this interpretation rather than the histo-
genic model oftumour antigens. However,
there is evidence, especially in the case
of melanoma, that histogenically deter-
mined tumour-specific antigens are present
(McCoy et al., 1975; Stuhlmiller and
Seigler, 1975; Shiku et al., 1976) but
differences in approach make direct com-
parisons difficult.
There are several possible reasons why
histogenic tumour-specific antigens were
not detected in the present study. Firstly,
cells used for immunization may be
mesothelial rather than tumour cells.
If that were the case, the common
antigens detected would be mesothelial.
However, absorption with normal pleural
cells should have removed antibodies to
these antigens, whereas in spite ofabsorp-
tion with these cells, the common "tumour
activity" remained. Secondly, as the
tumour cells were derived from metastatic
deposits, they may be less immunogenic
than those found on the parent cell
population. Thirdly, rabbits may not
possess the antibody diversity to recogniize
the antigens in question, or to dis-
criminate between them as between human
isoantigens (Schulman et al., 1964). Good-
win et al. (1972) produced heteroantisera
to human melanoma in rabbits and
claimed to detect melanoma-specific anti-
bodies. However, the technique used
couild not discriminate between cyto-
plasmic or membrane antigens, so com-
parison between this work and ours is
difficult. The antibody titres in Goodwin's
studies and that of Oreaves et al. (1975)
were low and comparable with those
found in this paper after reactivity to
normal cells had been lost. However,
these titres could still be used as a
diagnostic or prognostic tool (Greaves et
al., 1975).
In this study, we have shown that
in 2/4 cases, antibodies binding to tumour-
cell surfaces can be detected in rabbit
antisera after extensive absorption with
"normal" non-tumour cells. This varia-
bility may reflect differences between the
tumour cells used for immunization or
may be due to variability in responses
on the part of different rabbits. XVhile
the exact nature ofthe common reactivity
to tumour cells found in these experiments
has yet to be determined, the availability
of these antisera permits further in-
vestigation of cells in solid tumours and
fresh effusions. Furthermore, the method-
ology described here should be of general
application in the analysis of other
systems such as the analysis of sera of
cancer patients.
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